Demonising Justin Gatlin
13th September 2015
USADA announced today that Jack Casey, of Smithtown, N.Y., an athlete in the sport of swimming, has accepted a six-month sanction for an anti-doping rule violation. Casey, 17, tested positive for anastrozole as the result of an in-competition urine sample he provided at the AT&T Winter Nationals on December 1, 2017. Anastrozole is a Specified Substance in the class of Hormone and Metabolic Modulators and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the Fédération Internationale de Natation (FINA) Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the WADA Prohibited List.
After a thorough review of the case, including the examination of medical records provided by the athlete, USADA determined that Casey’s positive test was caused by a prescribed medication he was using in a therapeutic dose under the care of a physician. Although the substance was taken at the direction of a physician, the World Anti-Doping Code requires athletes to obtain a Therapeutic Use Exemption (TUE) before using a prohibited substance. Casey no longer has a need for the prescribed medication and, therefore, no TUE is necessary moving forward.
Casey’s six-month period of ineligibility began on March 22, 2018, the date his provisional suspension began. In addition, Casey has been disqualified from all competitive results obtained at the AT&T Winter Nationals, including the date his positive sample was collected and forfeiture of any medals, points and prizes.
• This media release was published by the US Anti-Doping Agency (USADA) on 26 July 2018. Click here for the original.